SCI-Expanded
JCR Q3
Özgün Makale
Scopus
Relationship of kynurenine pathway metabolites and indoleamine 2,3-dioxygenase with atherosclerosis: data obtained from pericardial fluid in coronary artery bypass surgery
Scandinavian Journal of Clinical and Laboratory Investigation
2025
Cilt 85
Sayı 6
Scopus Eşleşmesi Bulundu
0
Atıf
85
Cilt
509-517
Sayfa
Özet
Analyzing the local pericardial fluid (PF) surrounding the heart can provide insights into the function of myocardial and pericardial epithelial cells. Kynurenine (KYN) metabolites have been associated with endothelial dysfunction and the progression of atherosclerosis. This study investigated the relationship between KYN pathway metabolites in serum and PF and the severity of coronary atherosclerosis, as assessed by the Syntax Score (SS). The study involved 101 patients (mean age: 60 years). Of the participants, 17% were female. KYN and its metabolite levels were measured using API SCIEX 3200 LC-MS/MS methods. Statistical analysis was performed using IBM SPSS 25.0. The mean serum levels of tryptophan (TRP), 3-hydroxykynurenine (3-HK), and 3-hydroxyanthranilic acid were significantly higher (p < 0.01) when compared to the mean PF levels. In the SS-low group, PF IDO activity was significantly higher than serum IDO activity (p = 0.040). In the SS-high group, PF IDO activity was significantly higher than serum IDO activity (p = 0.002). The mean 3-HK measurements showed significant differences between the SS groups (p < 0.05). In this study, higher IDO enzyme activity in the PF compared to systemic circulation suggests the presence of inflammatory activity in the pericardial endothelial cells. This research aimed to uncover the role of amino acid metabolism, which is poorly understood in atherosclerosis. Specifically, 3-HK, a metabolite from the KYN pathway, may contribute to the development of atherosclerosis. These findings indicate that localized kynurenine pathway activation in the PF may contribute to coronary atherosclerosis, highlighting its potential as a biomarker or therapeutic target.
Web of Science Eşleşmesi Bulundu
0
WoS Atıf
85
Cilt
Article
Belge Türü
Kaynak: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
· s. 509-517
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2025 yılı verileri
Scandinavian Journal of Clinical and Laboratory Investigation
Q3
SJR Quartile
0,493
SJR Skoru
78
H-Index
Kategoriler: Clinical Biochemistry (Q3) · Medicine (miscellaneous) (Q3)
Alanlar: Biochemistry, Genetics and Molecular Biology · Medicine
Ülke: United Kingdom
· Taylor and Francis Ltd.
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Scandinavian Journal of Clinical and Laboratory Investigation
ISSN
0036-5513
Yıl
2025
/ 8. ay
Cilt / Sayı
85
/ 6
Sayfalar
509 – 517
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q3
Teşvik Puanı
1,29
· YÖKSİS Akademik Teşvik
Yayın Dili
Türkçe
Kapsam
Uluslararası
Toplam Yazar
7 kişi
Erişim Türü
Basılı+Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Tıbbi Biyokimya
YÖKSİS Yazar Kaydı
Yazar Adı
ÇOMAKLI HAKAN,Bik Mohammad Ahmad,ÜNLÜ ALİ,ABUŞOĞLU SEDAT,YİĞİTBAŞI MEHMET MURAT,Demirsöz Mert,KÜÇÜKER ŞEREF ALP
YÖKSİS ID
9019811